Anatomic endpoints support sustained outcomes with faricimab 16 weekly dosing (q16w) in the stairway phase 2 trial for neovascular age-related macular degeneration (nAMD)
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要